France Metagenomics Market Size, Share, and COVID-19 Impact Analysis, By Technology (Shotgun Sequencing, Whole Genome Sequencing), By Product (Kits & Reagents, Sequencing & Data Analytics Services and Software), and France Metagenomics Market Insights, Industry Trend, Forecasts to 2035.
Industry: HealthcareFrance Metagenomics Market Insights Forecasts to 2035
- The France Metagenomics Market Size was estimated at USD 84.2 Million in 2024
- The Market Size is Expected to Grow at a CAGR of around 13.00% from 2025 to 2035
- The France Metagenomics Market Size is Expected to Reach USD 323.1 Million by 2035
Get more details on this report -
According to a research report published by Spherical Insights & Consulting, The France Metagenomics Market Size is anticipated to reach USD 323.1 Million by 2035, growing at a CAGR of 13.00% from 2025 to 2035. This is because the main driver of this market's expansion is the falling cost of sequencing. Drop-Seq and other cutting-edge technologies have become powerful whole-genome sequencing tools that make it possible to analyse many cells at a reasonable cost.
Market Overview
The France metagenomics market is concerned with studying genetic constituents obtained directly from environmental samples, allowing researchers to study microbial communities without isolating and culturing individual microbes. In essence, it involves studying the genomes of all microbes from any environment. This field of study has changed the way we think about microbial diversity and function, and their roles in many ecosystems, including the human body. The decreasing cost of sequencing is expected to increase the use of metagenomics across various activities. As a result, numerous genome-related programs have been launched at the national level in the last few years. Initiatives taken strategically by universities and companies to pursue these new technologies are expected to contribute to market growth. The first driver of growth in this market is reducing sequencing costs. The adoption of new technologies, such as Drop-Seq, is generating new possibilities for whole-genome sequencing and challenging the assumption that sequencing costs always reflect the sequencing of a fixed number of cells, making it economical to analyze many cells.
Report Coverage
This research report categorizes the market for the France metagenomics market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France metagenomics market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France metagenomics market.
France Metagenomics Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Market Size in 2024: | USD 84.2 Million |
Forecast Period: | 2025-2035 |
Forecast Period CAGR 2025-2035 : | 13.00% |
2035 Value Projection: | USD 323.1 Million |
Historical Data for: | 2020-2023 |
No. of Pages: | 230 |
Tables, Charts & Figures: | 110 |
Segments covered: | By Technology, By Product |
Companies covered:: | Bio-Rad Laboratories, Inc, Illumina, Inc., Takara Bio, Inc., Novogene Co., Ltd., Oxford Nanopore Technologies, QIAGEN, Thermo Fisher Scientific, Inc., Promega Corporation, and Others |
Pitfalls & Challenges: | COVID-19 Impact, Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The France metagenomics market is driven by the burgeoning number of patents for systems & methods for metagenomics reflects this growing interest and innovation in the area. Further adoption will likely also be stimulated by the development of biotech tools that enable laboratory workflows to be streamlined. Developments in bioinformatics relate to a clearer market strategy to offer better verification & data analysis capabilities, which are expected to help spur the French market growth.
Restraining Factors
There are a number of challenges in the France metagenomics market, including sample collection, DNA extraction, and data analysis, and common standards for different types of research environments. Another major impediment includes costly metagenomic sequencing, which is accompanied by the need for experts trained in the field.
Market Segmentation
The France metagenomics market share is classified into technology and product.
- The shotgun sequencing segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The France metagenomics market is segmented by technology into shotgun sequencing, whole genome sequencing. Among these, the shotgun sequencing segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. By randomly dividing DNA into tiny pieces and sequencing each one, shotgun sequencing can sequence entire genomes. It is widely used in clinical diagnostics, genomics research, and a number of other industries, including agriculture and crop improvement, environmental monitoring, and conservation.
- The kits & reagents segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The France metagenomics market is segmented by product into kits & reagents, sequencing & data analytics services, and software. Among these, the kits & reagents segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. Reagents and kits are made for particular uses, like the analysis of biological, water, and soil samples. Depending on the needs of the study, these are frequently used to screen for bacteria, viruses, pathogens, fungi, and micro-eukaryotic species.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France metagenomics market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Bio-Rad Laboratories, Inc
- Illumina, Inc.
- Takara Bio, Inc.
- Novogene Co., Ltd.
- Oxford Nanopore Technologies
- QIAGEN
- Thermo Fisher Scientific, Inc.
- Promega Corporation
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France Metagenomics Market based on the below-mentioned segments:
France Metagenomics Market, By Technology
- Shotgun Sequencing
- Whole Genome Sequencing
France Metagenomics Market, By Product
- Kits & Reagents
- Sequencing & Data Analytics Services
- Software
Need help to buy this report?